In order to identify "the optimal dosage", participants in group I will be randomly selected to take either placebo, or BAF312 in doses of 0.5 mg/day, 2 mg/day, or 10 mg/day and will be regularly controlled in order to measure and determine the effectiveness, the tolerability and the safety of the dosages.
Da bi se odredile "optimalne doze", učesnici u grupi I će biti randomno izabrani da uzimaju bilo placebo, ili BAF312 u dozama od 0.5 mg/dan, 2 mg/dan, ili 10 mg/dan, i oni će biti redovno kontrolisani da bi se merila i utvrdila efektivnost, tolerancija i bezbednost doziranja.